TODD STRATEGY GROUP

Lobbying for FERRING PHARMACEUTICALS INC. · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Oct 12, 2025

Lobbying activity 1

Health Issues

Issues pertaining to reproductive health and access and coverage of infertility treatments and care. Issues related to infectious disease and hospital acquired infections.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.